EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy

Ricky Wirawan iD, Simon A Huber, Thomas Wein iD, Franz Bracher iD

Molecules · 2025

DOI: 10.3390/molecules30183821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ricky Wirawan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians University, Butenandtstr. 5-13, 81377 Munich, Germany. Hauptthemen laut MEDLINE: Sirtuins, Histone Deacetylase Inhibitors. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sirtuin 5 is an NAD+-dependent lysine deacylase that is involved in various biological processes and has emerged as a promising target for pharmaceutical therapies. The development of highly potent and subtype-selective sirtuin 5 inhibitors for their application as chemical tools and drug candidates still poses a significant challenge. Based on our own optimized balsalazide-derived sirtuin 5 inhibitors, this work presents a systematic investigation of the inhibitory effects of derivatives with moieties that were guided by docking experiments to target the nicotinamide ribose vicinal hydroxy groups of the essential co-factor NAD+ via reversible covalent binding to potentially enhance their potency. Our results show that functionalizations with these moieties were tolerated to some extent and possessed a distinct stereo-selective preference. The (S)-configured cyanomethyl derivative 50 with an IC50 of 27 µM emerged from our synthesized library of compounds as the most potent functionalized inhibitor and lies in a similar potency range to other established sirtuin 5 inhibitors. Our findings offer a deeper insight into the structure–activity relationships of our balsalazide-derived heterotriaryl-based sirtuin 5 inhibitors and thus could provide an avenue for further optimizations in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirtuinsHistone Deacetylase InhibitorsStructure-Activity RelationshipMolecular Docking SimulationHumansMolecular Structure

Stichwörter der Autor:innen

Sirt5 inhibitorbalsalazideco-factor NAD+histone deacetylasesreversible covalent inhibitorsirtuin 5 inhibitorstructure–activity relationship

Substanzen

SirtuinsSIRT5 protein, humanHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy-Center for Drug Research, Ludwig-Maximilians University, Butenandtstr. 5-13, 81377 Munich, Germany.

ORCID-Profile: Ricky Wirawan, Thomas Wein, Franz Bracher

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Wirawan, R., Huber, S. A., Wein, T., & Bracher, F. (2025). Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy. Molecules. https://doi.org/10.3390/molecules30183821

Vancouver

Wirawan R, Huber SA, Wein T, Bracher F. Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy. Molecules. 2025. doi:10.3390/molecules30183821

BibTeX
@article{Wirawan2025,
  author = {Wirawan, Ricky and Huber, Simon A and Wein, Thomas and Bracher, Franz},
  title = {Balsalazide-Derived Heterotriaryls as Sirtuin 5 Inhibitors: A Case Study of a Reversible Covalent Inhibition Strategy},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30183821}
}
Kostenlos starten →